Glutamate receptors as therapeutic targets

被引:0
|
作者
Javitt D.C. [1 ]
机构
[1] Nathan Kline Inst. Psychiat. Res., New York Univ. School of Medicine
关键词
D O I
10.1038/sj.mp.4001602
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:979 / 979
相关论文
共 50 条
  • [21] Cannabinoid receptors as therapeutic targets
    Mackie, K
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 : 101 - 122
  • [22] Cannabinoid receptors as therapeutic targets
    Pavlopoulos, Spiro
    Thakur, Ganesh A.
    Nikas, Spyros P.
    Makriyannis, Alexandros
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (14) : 1751 - 1769
  • [23] Nuclear receptors as therapeutic targets
    Giembycz, MA
    Palmer, AM
    Horton, RW
    DRUG NEWS & PERSPECTIVES, 1999, 12 (10) : 641 - 646
  • [24] Adenosine receptors as therapeutic targets
    Jacobson, KA
    Gao, ZG
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (03) : 247 - 264
  • [25] GLYCINE RECEPTORS AS THERAPEUTIC TARGETS
    Lynch, J. W.
    Lynagh, T.
    JOURNAL OF NEUROCHEMISTRY, 2010, 115 : 60 - 60
  • [26] Adenosine receptors as therapeutic targets
    Kenneth A. Jacobson
    Zhan-Guo Gao
    Nature Reviews Drug Discovery, 2006, 5 : 247 - 264
  • [27] Reactive Astrocytes as Therapeutic Targets for Brain Degenerative Diseases: Roles Played by Metabotropic Glutamate Receptors
    Talia M. Planas-Fontánez
    Cheryl F. Dreyfus
    Kyle S. Saitta
    Neurochemical Research, 2020, 45 : 541 - 550
  • [28] Reactive Astrocytes as Therapeutic Targets for Brain Degenerative Diseases: Roles Played by Metabotropic Glutamate Receptors
    Planas-Fontanez, Talia M.
    Dreyfus, Cheryl F.
    Saitta, Kyle S.
    NEUROCHEMICAL RESEARCH, 2020, 45 (03) : 541 - 550
  • [29] Glutamate receptors as novel targets of antiplatelet therapy
    Sun, Henry
    Swaim, Anne
    Thompson, Laura
    Lowenstein, Charles
    Morrell, Craig
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E36 - E36
  • [30] Are metabotropic glutamate receptors new targets for antipsychotics?
    Kinon, B.
    Zhang, L.
    Breier, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S155 - S155